Xenetic Biosciences (XBIO) Gains from Investment Securities (2023 - 2025)

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Xenetic Biosciences (XBIO) has disclosed Gains from Investment Securities for 2 consecutive years, with -$704431.0 as the latest value for Q4 2024.

• For the quarter ending Q4 2024, Gains from Investment Securities fell 324.4% year-over-year to -$704431.0, compared with a TTM value of -$704431.0 through Sep 2025, down 324.4%, and an annual FY2024 reading of -$704431.0, down 1350.07% over the prior year.
• Gains from Investment Securities was -$704431.0 for Q4 2024 at Xenetic Biosciences, down from $313921.0 in the prior quarter.
• Across five years, Gains from Investment Securities topped out at $313921.0 in Q4 2023 and bottomed at -$704431.0 in Q4 2024.

Peer Comparison